Europe Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type (Post-exposure Prophylaxis, and Pre-exposure prophylaxis), By End User, By Application (Human, and Animal), By Product Type, By Country and Growth Forecast, 2023 - 2030

The Europe Rabies Vaccine Market would witness market growth of 4.1% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Rabies Vaccine Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $101 Million by 2030. The UK market is exhibiting a CAGR of 3.2% during (2023 - 2030). Additionally, The France market would experience a CAGR of 4.9% during (2023 - 2030).

Professionals working in high-risk occupations, such as wildlife researchers, animal handlers, and veterinarians, may receive these vaccines to mitigate the risk of exposure during their work. This targeted vaccination strategy helps protect individuals regularly in close contact with animals, who may be more likely to encounter the rabies virus. These vaccines are crucial in emergency response situations, such as outbreaks or clusters of rabies cases.

Furthermore, dogs are the primary reservoirs and transmitters of the rabies virus to humans. Unvaccinated dogs carry a considerable risk of rabies transmission through bites in regions where the disease is endemic. The prevalence of dog bites, especially in areas with a high population of stray or unvaccinated dogs, underscores the urgent need for effective rabies vaccination programs.

Rabies is a zoonotic disease that threatens public health in France. The occurrence of rabies cases prompts public health authorities to implement preventive measures, including the vaccination of domestic animals and public awareness campaigns to reduce the risk of human exposure in France. Like many European countries, France has legal requirements for rabies vaccination of domestic animals, particularly dogs and cats. Veterinarians are pivotal in recommending and administering these vaccines to domestic animals in France. The increased incidence of rabies cases may lead to heightened awareness among pet owners, who are more likely to follow veterinary recommendations for vaccination in France. Thus, all these factors will uplift the regional market’s expansion in the coming years.

Free Valuable Insights: The Global Rabies Vaccine Market will Hit USD 1.6 Billion by 2030, at a CAGR of 4.5%

Based on Prophylaxis Type, the market is segmented into Post-exposure Prophylaxis, and Pre-exposure prophylaxis. Based on End User, the market is segmented into Hospitals, Veterinary Clinics, and Others. Based on Application, the market is segmented into Human, and Animal. Based on Product Type, the market is segmented into Chick Embryo Cells Rabies Vaccine, Human Diploid Cell Vaccine, Vero cell rabies vaccine, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Boehringer Ingelheim International GmbH
• Cadila Pharmaceuticals Limited
• Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
• Elanco Animal Health, Inc.
• Zoetis, Inc.
• Merck & Co., Inc.
• Novartis AG
• Bharat Biotech Ltd.
• Sanofi S.A.
• Virbac

Europe Rabies Vaccine Market Report Segmentation

By Prophylaxis Type

• Post-exposure Prophylaxis
• Pre-exposure prophylaxis

By End User

• Hospitals
• Veterinary Clinics
• Others

By Application

• Human
• Animal

By Product Type

• Chick Embryo Cells Rabies Vaccine
• Human Diploid Cell Vaccine
• Vero cell rabies vaccine
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Rabies Vaccine Market, by Prophylaxis Type
1.4.2 Europe Rabies Vaccine Market, by End User
1.4.3 Europe Rabies Vaccine Market, by Application
1.4.4 Europe Rabies Vaccine Market, by Product Type
1.4.5 Europe Rabies Vaccine Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Europe Rabies Vaccine Market by Prophylaxis Type
4.1 Europe Post-exposure Prophylaxis Market by Country
4.2 Europe Pre-exposure prophylaxis Market by Country

Chapter 5. Europe Rabies Vaccine Market by End User
5.1 Europe Hospitals Market by Country
5.2 Europe Veterinary Clinics Market by Country
5.3 Europe Others Market by Country

Chapter 6. Europe Rabies Vaccine Market by Application
6.1 Europe Human Market by Country
6.2 Europe Animal Market by Country

Chapter 7. Europe Rabies Vaccine Market by Product Type
7.1 Europe Chick Embryo Cells Rabies Vaccine Market by Country
7.2 Europe Human Diploid Cell Vaccine Market by Country
7.3 Europe Vero Cell Rabies Vaccine Market by Country
7.4 Europe Others Market by Country

Chapter 8. Europe Rabies Vaccine Market by Country
8.1 Germany Rabies Vaccine Market
8.1.1 Germany Rabies Vaccine Market by Prophylaxis Type
8.1.2 Germany Rabies Vaccine Market by End User
8.1.3 Germany Rabies Vaccine Market by Application
8.1.4 Germany Rabies Vaccine Market by Product Type
8.2 UK Rabies Vaccine Market
8.2.1 UK Rabies Vaccine Market by Prophylaxis Type
8.2.2 UK Rabies Vaccine Market by End User
8.2.3 UK Rabies Vaccine Market by Application
8.2.4 UK Rabies Vaccine Market by Product Type
8.3 France Rabies Vaccine Market
8.3.1 France Rabies Vaccine Market by Prophylaxis Type
8.3.2 France Rabies Vaccine Market by End User
8.3.3 France Rabies Vaccine Market by Application
8.3.4 France Rabies Vaccine Market by Product Type
8.4 Russia Rabies Vaccine Market
8.4.1 Russia Rabies Vaccine Market by Prophylaxis Type
8.4.2 Russia Rabies Vaccine Market by End User
8.4.3 Russia Rabies Vaccine Market by Application
8.4.4 Russia Rabies Vaccine Market by Product Type
8.5 Spain Rabies Vaccine Market
8.5.1 Spain Rabies Vaccine Market by Prophylaxis Type
8.5.2 Spain Rabies Vaccine Market by End User
8.5.3 Spain Rabies Vaccine Market by Application
8.5.4 Spain Rabies Vaccine Market by Product Type
8.6 Italy Rabies Vaccine Market
8.6.1 Italy Rabies Vaccine Market by Prophylaxis Type
8.6.2 Italy Rabies Vaccine Market by End User
8.6.3 Italy Rabies Vaccine Market by Application
8.6.4 Italy Rabies Vaccine Market by Product Type
8.7 Rest of Europe Rabies Vaccine Market
8.7.1 Rest of Europe Rabies Vaccine Market by Prophylaxis Type
8.7.2 Rest of Europe Rabies Vaccine Market by End User
8.7.3 Rest of Europe Rabies Vaccine Market by Application
8.7.4 Rest of Europe Rabies Vaccine Market by Product Type

Chapter 9. Company Profiles
9.1 Cadila Pharmaceuticals Limited
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Product Launches and Product Expansions:
9.2 Bharat Biotech Ltd.
9.2.1 Company Overview
9.3 Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
9.3.1 Company Overview
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Elanco Animal Health, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 SWOT Analysis
9.6 Zoetis, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Merck & Co., Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Novartis AG
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Sanofi S.A.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Virbac
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 SWOT Analysis

TABLE 1 Europe Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 2 Europe Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 3 Europe Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 4 Europe Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 5 Europe Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 10 Europe Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 11 Europe Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Veterinary Clinics Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Veterinary Clinics Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 18 Europe Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 19 Europe Human Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Human Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Animal Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Animal Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 24 Europe Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 25 Europe Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 29 Europe Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 32 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 33 Europe Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 35 Germany Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 36 Germany Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 37 Germany Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 38 Germany Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 39 Germany Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 40 Germany Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 41 Germany Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 42 Germany Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 43 Germany Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 44 Germany Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 45 UK Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 46 UK Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 47 UK Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 48 UK Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 49 UK Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 50 UK Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 51 UK Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 52 UK Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 53 UK Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 54 UK Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 55 France Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 56 France Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 57 France Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 58 France Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 59 France Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 60 France Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 61 France Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 62 France Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 63 France Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 64 France Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 65 Russia Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 66 Russia Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 67 Russia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 68 Russia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 69 Russia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 70 Russia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 71 Russia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 72 Russia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 73 Russia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 74 Russia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 75 Spain Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 76 Spain Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 77 Spain Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 78 Spain Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 79 Spain Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 80 Spain Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 81 Spain Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 82 Spain Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 83 Spain Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 84 Spain Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 85 Italy Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 86 Italy Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 87 Italy Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 88 Italy Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 89 Italy Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 90 Italy Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 91 Italy Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 92 Italy Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 93 Italy Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 94 Italy Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 95 Rest of Europe Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 96 Rest of Europe Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 97 Rest of Europe Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 98 Rest of Europe Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 99 Rest of Europe Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 100 Rest of Europe Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 101 Rest of Europe Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 102 Rest of Europe Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 103 Rest of Europe Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 104 Rest of Europe Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 105 Key Information – Cadila Pharmaceuticals Limited
TABLE 106 Key Information – Bharat Biotech Ltd.
TABLE 107 Key Information – Serum Institute of India Pvt. Ltd.
TABLE 108 Key Information – Boehringer Ingelheim International GmbH
TABLE 109 Key information – Elanco Animal Health, Inc.
TABLE 110 Key Information – Zoetis, Inc.
TABLE 111 Key Information - Merck & Co., Inc.
TABLE 112 Key Information – Novartis AG
TABLE 113 Key Information – Sanofi S.A.
TABLE 114 Key Information – Virbac

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Rabies Vaccine Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Rabies Vaccine Market
FIG 4 Porter’s Five Forces Analysis – Rabies Vaccine Market
FIG 5 Europe Rabies Vaccine Market share by Prophylaxis Type, 2022
FIG 6 Europe Rabies Vaccine Market share by Prophylaxis Type, 2030
FIG 7 Europe Rabies Vaccine Market by Prophylaxis Type, 2019 - 2030, USD Million
FIG 8 Europe Rabies Vaccine Market share by End User, 2022
FIG 9 Europe Rabies Vaccine Market share by End User, 2030
FIG 10 Europe Rabies Vaccine Market by End User, 2019 - 2030, USD Million
FIG 11 Europe Rabies Vaccine Market share by Application, 2022
FIG 12 Europe Rabies Vaccine Market share by Application, 2030
FIG 13 Europe Rabies Vaccine Market by Application, 2019 - 2030, USD Million
FIG 14 Europe Rabies Vaccine Market share by Product Type, 2022
FIG 15 Europe Rabies Vaccine Market share by Product Type, 2030
FIG 16 Europe Rabies Vaccine Market by Product Type, 2019 - 2030, USD Million
FIG 17 Europe Rabies Vaccine Market share by Country, 2022
FIG 18 Europe Rabies Vaccine Market share by Country, 2030
FIG 19 Europe Rabies Vaccine Market by Country, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 21 SWOT Analysis: Elanco Animal Health, Inc.
FIG 22 Swot Analysis: ZOETIS, INC.
FIG 23 SWOT Analysis: Merck & Co., Inc.
FIG 24 SWOT Analysis: Novartis AG
FIG 25 Swot Analysis: Sanofi S.A.
FIG 26 SWOT Analysis: Virbac